Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 9;24(4):3494.
doi: 10.3390/ijms24043494.

Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases

Affiliations
Review

Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases

Albert Stec et al. Int J Mol Sci. .

Abstract

Dysbiosis has been identified in many dermatological conditions (e.g., psoriasis, atopic dermatitis, systemic lupus erythematosus). One of the ways by which the microbiota affect homeostasis is through microbiota-derived molecules (metabolites). There are three main groups of metabolites: short-chain fatty acids (SCFAs), tryptophan metabolites, and amine derivatives including trimethylamine N-oxide (TMAO). Each group has its own uptake and specific receptors through which these metabolites can exert their systemic function. This review provides up-to-date knowledge about the impact that these groups of gut microbiota metabolites may have in dermatological conditions. Special attention is paid to the effect of microbial metabolites on the immune system, including changes in the profile of the immune cells and cytokine disbalance, which are characteristic of several dermatological diseases, especially psoriasis and atopic dermatitis. Targeting the production of microbiota metabolites may serve as a novel therapeutic approach in several immune-mediated dermatological diseases.

Keywords: SCFA; TMAO; dysbiosis; fecal microbiota transplantation; gut–skin axis; immune-mediated inflammatory diseases; inflammation; intestinal microbial metabolites; microbiota; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Three pathways of tryptophan metabolism. The indole pathway is mostly associated with intestinal microbiota metabolism. Various compounds produced in this pathway are considered beneficial to human health. I3A—indole-3-aldehyde, ILA—indole lactic acid, IPA—indole propionic acid, IPyr—indole pyruvate, IAA—indole acetic acid. Created with BioRender.com.
Figure 2
Figure 2
Production of microbiota metabolites and potential treatment options at various steps of this process. Ingested food is rich in compounds that can be utilized by intestinal microbiota. End products of microbiota metabolism are absorbed into the circulation. 1. Prebiotics, e.g., fructooligosaccharides and inulins, can be supplemented to achieve growth of beneficial microorganisms and an increase in production of eligible metabolites. 2. Probiotics. 3. Fecal microbiota transplantation is carried out with the aim to replace pathogenic bacteria with health-promoting ones. 4. Postbiotics consist of favorable metabolites of intestinal microbiota. Created with BioRender.com.

Similar articles

Cited by

References

    1. Ipci K., Altintoprak N., Muluk N.B., Senturk M., Cingi C. The possible mechanisms of the human microbiome in allergic diseases. Eur. Arch. Otorhinolaryngol. 2017;274:617–626. doi: 10.1007/s00405-016-4058-6. - DOI - PubMed
    1. Alesa D.I., Alshamrani H.M., Alzahrani Y.A., Alamssi D.N., Alzahrani N.S., Almohammadi M.E. The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics. J. Family Med. Prim. Care. 2019;8:3496–3503. doi: 10.4103/jfmpc.jfmpc_709_19. - DOI - PMC - PubMed
    1. Myers B., Brownstone N., Reddy V., Chan S., Thibodeaux Q., Truong A., Bhutani T., Chang H.W., Liao W. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract. Res. Clin. Rheumatol. 2019;33:101494. doi: 10.1016/j.berh.2020.101494. - DOI - PubMed
    1. Sikora M., Stec A., Chrabaszcz M., Knot A., Waskiel-Burnat A., Rakowska A., Olszewska M., Rudnicka L. Gut Microbiome in Psoriasis: An Updated Review. Pathogens. 2020;9:463. doi: 10.3390/pathogens9060463. - DOI - PMC - PubMed
    1. Hevia A., Milani C., López P., Cuervo A., Arboleya S., Duranti S., Turroni F., González S., Suárez A., Gueimonde M., et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio. 2014;5:e01548-14. doi: 10.1128/mBio.01548-14. - DOI - PMC - PubMed

Substances

LinkOut - more resources